Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Equity Ratio (2016 - 2018)

Armata Pharmaceuticals' Equity Ratio history spans 6 years, with the latest figure at 0.83 for Q3 2018.

  • For Q3 2018, Equity Ratio rose 16.99% year-over-year to 0.83; the TTM value through Sep 2018 reached 0.83, up 16.99%, while the annual FY2017 figure was 2.19, 308.05% up from the prior year.
  • Equity Ratio for Q3 2018 was 0.83 at Armata Pharmaceuticals, down from 0.99 in the prior quarter.
  • Across five years, Equity Ratio topped out at 2.19 in Q4 2017 and bottomed at 0.91 in Q1 2014.
  • The 5-year median for Equity Ratio is 0.5 (2016), against an average of 0.48.
  • The largest annual shift saw Equity Ratio soared 495.1% in 2016 before it dropped 11.04% in 2017.
  • A 5-year view of Equity Ratio shows it stood at 0.12 in 2014, then skyrocketed by 282.69% to 0.46 in 2015, then rose by 16.53% to 0.54 in 2016, then skyrocketed by 308.05% to 2.19 in 2017, then crashed by 62.1% to 0.83 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Equity Ratio are 0.83 (Q3 2018), 0.99 (Q2 2018), and 1.02 (Q1 2018).